Skip to main content

BLAP75 293T Cell Transient Overexpression Lysate, Novus Biologicals

Bio-Techne includes Novus Biologicals | Catalog # H00080010-T02

Catalog #
Availability
Size / Price
Qty
Loading...
H00080010-T02

Key Product Details

Species

Human

Applications

Western Blot

Product Summary for BLAP75 293T Cell Transient Overexpression Lysate

Quality control test: Transient overexpression cell lysate was tested with Anti-RMI1 antibody by Western Blots. Plasmid: pCMV-RMI1 full-length

Product Specifications

Specificity

BLAP75 293T Cell Transient Overexpression Lysate(Denatured)

Type

293T Cell Transient Overexpression

Protein State

Denatured

Formulation, Preparation, and Storage

Formulation

1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)

Concentration

Please contact technical services for concentration.

Shipping

The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.

Storage

Store at -80C. Avoid freeze-thaw cycles.

Background: BLAP75

Plasmid: pCMV-C9orf76 Full length; Host Cell: 293T

Alternate Names

75 kDa, BLM-associated protein 75 kDa, BLM-associated protein of 75 kDa, chromosome 9 open reading frame 76, FAAP75, FLJ12888, homolog of yeast RecQ-mediated genome instability 1 (RMI1), recQ-mediated genome instability protein 1, RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae), RMI2

Gene Symbol

RMI1

Additional BLAP75 Products

Product Documents for BLAP75 293T Cell Transient Overexpression Lysate

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for BLAP75 293T Cell Transient Overexpression Lysate

This product is produced by and distributed for Abnova, a company based in Taiwan.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Lysates are guaranteed for 6 months from date of receipt.

Loading...
Loading...
Loading...
Loading...